Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)

152.42
Delayed Data
As of 4:00pm ET
 +3.72 / +2.50%
Today’s Change
117.16
Today|||52-Week Range
163.75
+13.20%
Year-to-Date

Today’s Trading

Previous close148.70
Today’s open149.51
Day’s range148.73 - 152.46
Volume508,612
Average volume (3 months)455,164
Market cap$8.9B
Data as of 4:00pm ET, 01/22/2018

Growth & Valuation

Earnings growth (last year)+22.56%
Earnings growth (this year)+9.03%
Earnings growth (next 5 years)+14.21%
Revenue growth (last year)+12.32%
P/E ratio25.1
Price/Sales4.53
Price/Book4.74

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...+6.17+4.94%
ALKSAlkermes Plc+0.59+1.03%
SGENSeattle Genetics Inc+2.81+5.25%
TSROTESARO Inc+4.31+6.74%
Data as of 4:00pm ET, 01/22/2018

Financials

Next reporting dateFebruary 27, 2018
EPS forecast (this quarter)$2.98
Annual revenue (last year)$1.5B
Annual profit (last year)$396.8M
Net profit margin26.67%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Bruce C. Cozadd
President &
Chief Operating Officer
Daniel N. Swisher
Corporate headquarters
Dublin, Dublin

Forecasts